title: Six-year follow-up of azathioprine and mycophenolate mofetil use during the first 6 months of renal transplantation.
abstract: Long-term follow-up examination to test whether therapy with mycophenolate mofetil (MMF) or azathioprine (AZA) during the first year translates into different graft or patient survival and graft function is important. Therefore, 6-year follow-up data of a group of 80 consecutive renal transplant recipients were analyzed. The first group of 40 patients was treated with AZA, cyclosporine and prednisone and the second group with MMF, cyclosporine and prednisone for the first 6 months. Graft failure rates were compared during follow-up. Creatinine, inverse slope of creatinine (delta/creatinine) and 24-hour proteinuria at 6 years post transplantation were compared. The Kaplan-Meier analyses for death-censored and non-censored graft failure showed no difference between the groups. Creatinine values at 6 years for the AZA Group were 139 +/- 36 micromol/l (95% CI 125.9-151.2 micromol/l) and for the MMF Group 149 +/- 52 micromol/l (95% CI 133.9-164.9 micromol/l). Delta/creatinine and 24-hour proteinuria at 6 years did not differ between the two groups. We conclude that an initial 6-month treatment with MMF as opposed to AZA reduced the early rejection rate, but did not result in superior long-term graft function or survival after 6 years of follow-up observation.
authors.affiliation: Clinic for Nephrology, University Hospital, Zürich, Switzerland.
authors.forename: S J
authors.initials: SJ
authors.lastname: Rippin
authors.forename: A L
authors.initials: AL
authors.lastname: Serra
authors.forename: H P
authors.initials: HP
authors.lastname: Marti
authors.forename: R P
authors.initials: RP
authors.lastname: Wüthrich
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D002423:Cause of Death; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000145:classification / Q000453:epidemiology; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D006454:Hemoglobins; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine